Current Duke Appointments & Affiliations
Professor of Medicine
·
2025 - Present
Medicine, Medical Oncology,
Medicine
Recent Scholarly Works
Mitochondrial DNA mutations are associated with impaired oxidative phosphorylation and enhanced imatinib response in chronic myeloid leukemia.
Journal article Hemasphere · September 2026 Mitochondrial DNA (mtDNA) mutations are frequently observed in cancer, but their clinical and functional significance in chronic myeloid leukemia (CML) remains incompletely defined. Here, we show that a distinct mtDNA mutational landscape is associated wit ... Full text Link to item CiteForging New Pathways in Oncology: Strategic Insights from the 17th Annual Frontiers in Cancer Science Conference.
Journal article Cancer Res · July 2, 2026 The 17th Annual Frontiers in Cancer Science (FCS) conference (2025) highlighted the convergence of multiomics, computational biology, and ancestry-specific genomics to advance proactive cancer care. Key insights included the role of epigenetic plasticity i ... Full text Link to item CiteEducation
University of Cambridge (United Kingdom) ·
1987
M.B.B.Ch.